PA
NERV icon

Perceptive Advisors’s Minerva Neurosciences NERV Stock Holding History

Perceptive Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-101,317
Closed -$6.57M – 151
2017
Q1 		$6.57M Hold
101,317
– – 0.37% 52
2016
Q4 		$9.52M Hold
101,317
– – 0.68% 37
2016
Q3 		$11.4M Hold
101,317
– – 0.74% 32
2016
Q2 		$8.28M Hold
101,317
– – 0.57% 41
2016
Q1 		$4.98M Hold
101,317
– – 0.44% 57
2015
Q4 		$4.92M Hold
101,317
– – 0.36% 53
2015
Q3 		$4.25M Hold
101,317
– – 0.34% 62
2015
Q2 		$4.7M Hold
101,317
– – 0.28% 69
2015
Q1 		$4.05M Buy
+101,317
New +$4.2M 0.31% 59

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Perceptive Advisors's NERV Position: Q2 2017 in Review

Perceptive Advisors sold out of Minerva Neurosciences (NERV) in Q2 2017, closing a stake of 101,317 shares — an estimated $6.57M sold.

Perceptive Advisors first reported a position in NERV in Q1 2015 and held it in 9 quarters. The position peaked at $11.4M in Q3 2016. 82 funds tracked by Wall St. Rank hold NERV as of Q2 2017.

  • Perceptive Advisors reported no remaining Minerva Neurosciences position as of Q2 2017 after selling out during the quarter.
  • Perceptive Advisors sold 101,317 Minerva Neurosciences shares in Q2 2017, an estimated $6.57M.
  • Perceptive Advisors first reported a position in Minerva Neurosciences in Q1 2015 and held it in 9 quarters.
  • Perceptive Advisors's Minerva Neurosciences position peaked at $11.4M in Q3 2016.
  • 82 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2017.

Based on Perceptive Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.